BioMedinvest

BioMedPartners is a European venture capital firm that provides private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. The company focuses on pharmaceuticals, biotechnology, diagnostics and medical technology. Founded 2003 in Basel, Switzerland by Gerhard Ries, this private equity and venture capital firm invests in early and late stage ventures. It funds Series A, Series B, Series D, grants and other venture roundsventure rounds. Its portfolio companies include Sequana Medical, Aleva Neurotherapeutics, ImmunOs Therapeutics, Inotrem,and Curetis. As of February 2020, the company has 19 exits and 67 investments.

BioMedPartners is a European venture capital firm that provides private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. The company focuses on pharmaceuticals, biotechnology, diagnostics and medical technology. Founded 2003 in Basel, Switzerland by Gerhard Ries, this private equity and venture capital firm invests in early and late stage ventures. It funds Series A, Series B, Series D, grants and other venture rounds. Its portfolio companies include Sequana MedicalSequana Medical, Aleva Neurotherapeutics, ImmunOs Therapeutics, Inotrem,and Curetis. As of February 2020, the company has 19 exits and 67 investments.

BioMedPartners is a European venture capital firm that provides private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. The company focuses on pharmaceuticals, biotechnology, diagnostics and medical technology. Founded 2003 in Basel, Switzerland by Gerhard RiesGerhard Ries, this private equity and venture capital firm invests in early and late stage ventures. It funds Series A, Series B, Series D, grants and other venture rounds. Its portfolio companies include Sequana Medical, Aleva Neurotherapeutics, ImmunOs Therapeutics, Inotrem,and Curetis. As of February 2020, the company has 19 exits and 67 investments.

BioMedPartners is a European venture capital firm that provides private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. The company focuses on pharmaceuticals, biotechnology, diagnostics and medical technology. Founded 2003 in Basel, Switzerland by Gerhard Ries, this private equity and venture capital firm invests in early and late stage ventures. It funds Series A, Series B, Series D, grants and other venture rounds. Its portfolio companies include Sequana Medical, Aleva Neurotherapeutics, ImmunOs Therapeutics, Inotrem,and CuretisCuretis. As of February 2020, the company has 19 exits and 67 investments.

BioMedPartners is a European venture capital firm that provides private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. The company focuses on pharmaceuticals, biotechnology, diagnostics and medical technology. Founded 2003 in BaselBasel, Switzerland by Gerhard Ries, this private equity and venture capital firm invests in early and late stage ventures. It funds Series A, Series B, Series D, grants and other venture rounds. Its portfolio companies include Sequana Medical, Aleva Neurotherapeutics, ImmunOs Therapeutics, Inotrem,and Curetis. As of February 2020, the company has 19 exits and 67 investments.

BioMedPartners is a European venture capital firm that provides private equityprivate equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. The company focuses on pharmaceuticals, biotechnology, diagnostics and medical technology. Founded 2003 in Basel, Switzerland by Gerhard Ries, this private equity and venture capital firm invests in early and late stage ventures. It funds Series A, Series B, Series D, grants and other venture rounds. Its portfolio companies include Sequana Medical, Aleva Neurotherapeutics, ImmunOs Therapeutics, Inotrem,and Curetis. As of February 2020, the company has 19 exits and 67 investments.

BioMedPartners is a European venture capital firm that provides private equity and mezzanine financing to early- and mid-stage healthcare and human life science companies. The company focuses on pharmaceuticals, biotechnology, diagnostics and medical technology. Founded 2003 in Basel, SwitzerlandSwitzerland by Gerhard Ries, this private equity and venture capital firm invests in early and late stage ventures. It funds Series A, Series B, Series D, grants and other venture rounds. Its portfolio companies include Sequana Medical, Aleva Neurotherapeutics, ImmunOs Therapeutics, Inotrem,and Curetis. As of February 2020, the company has 19 exits and 67 investments.